Invivoscribe gets Japanese nod for mutation assay as CDx for Daiichi Sankyos Quizartinib

Invivoscribe gets Japanese nod for mutation assay as CDx for Daiichi Sankyo’s Quizartinib

03:54 EDT 20 Jun 2019 | Compelo Medical Devices

LeukoStrat CDx FLT3 is a PCR-based and in vitro diagnostic test, which will help detect internal tandem duplication (ITD) mutations and tyrosine kinase domain (TKD) mutations D835 and

The post Invivoscribe gets Japanese nod for mutation assay as CDx for Daiichi Sankyo’s Quizartinib appeared first on NS Medical Devices.

More From BioPortfolio on "Invivoscribe gets Japanese nod for mutation assay as CDx for Daiichi Sankyo’s Quizartinib"